Relmada Therapeutics, Inc. (RLMD)

3.90 -0.06 (-1.52%) USD  |  NASDAQ  |  Jan 23, 16:00
3.91 +0.01 (+0.26%) After-Hours: 20:00
More

Relmada Therapeutics Payables and Accrued Expenses (Quarterly)

Payables and Accrued Expenses (Quarterly) Chart

View Payables and Accrued Expenses (Quarterly) for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Payables and Accrued Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Payables and Accrued Expenses (Quarterly) Benchmarks

View Payables and Accrued Expenses (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Invivyd, Inc. Upgrade
Arcellx, Inc. Upgrade
Puma Biotechnology, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade